Nevertheless, Manchester’s life sciences cluster has bounced back and evolved following AstraZeneca’s departure, Sheppard ...

Canary Wharf Group has joined forces with science facility developer Kadans on the project, which will kick off with the construction of a 22 storey, 750,000 sq. ft. building dedicated to a ...

To discuss this rich topic on today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director of Business ...

Manchester City Council announced a deal today (December 2) with Kadans Science Partner UK, who will turn a 215,000 sq ft brownfield site in Upper Brook Street into a major lab and office space.